Li M - Search Results

1

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

Yi K, Kong H, Zheng C, Zhuo C, Jin Y, Zhong Q, Mintz RL, Ju E, Wang H, Lv S, Lao YH, Tao Y, Li M. Yi K, et al. Among authors: li m. Biomaterials. 2023 Nov;302:122349. doi: 10.1016/j.biomaterials.2023.122349. Epub 2023 Oct 6. Biomaterials. 2023. PMID: 37844429

2

Polypeptide/doxorubicin hydrochloride polymersomes prepared through organic solvent-free technique as a smart drug delivery platform.

Li M, Lv S, Tang Z, Song W, Yu H, Sun H, Liu H, Chen X. Li M, et al. Macromol Biosci. 2013 Sep;13(9):1150-62. doi: 10.1002/mabi.201300222. Epub 2013 Jul 29. Macromol Biosci. 2013. PMID: 23894136

3

Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.

Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X. Lv S, et al. Among authors: li m. Acta Biomater. 2013 Dec;9(12):9330-42. doi: 10.1016/j.actbio.2013.08.015. Epub 2013 Aug 17. Acta Biomater. 2013. PMID: 23958784

4

Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.

Song W, Tang Z, Li M, Lv S, Sun H, Deng M, Liu H, Chen X. Song W, et al. Among authors: li m. Acta Biomater. 2014 Mar;10(3):1392-402. doi: 10.1016/j.actbio.2013.11.026. Epub 2013 Dec 6. Acta Biomater. 2014. PMID: 24316362

5

Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin.

Song W, Tang Z, Zhang D, Zhang Y, Yu H, Li M, Lv S, Sun H, Deng M, Chen X. Song W, et al. Among authors: li m. Biomaterials. 2014 Mar;35(9):3005-14. doi: 10.1016/j.biomaterials.2013.12.018. Epub 2014 Jan 2. Biomaterials. 2014. PMID: 24388813

6

Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.

Li M, Tang Z, Lv S, Song W, Hong H, Jing X, Zhang Y, Chen X. Li M, et al. Biomaterials. 2014 Apr;35(12):3851-64. doi: 10.1016/j.biomaterials.2014.01.018. Epub 2014 Feb 1. Biomaterials. 2014. PMID: 24495487

7

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.

Lv S, Tang Z, Li M, Lin J, Song W, Liu H, Huang Y, Zhang Y, Chen X. Lv S, et al. Among authors: li m. Biomaterials. 2014 Jul;35(23):6118-29. doi: 10.1016/j.biomaterials.2014.04.034. Epub 2014 May 1. Biomaterials. 2014. PMID: 24794923

8

Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer.

Li M, Tang Z, Lin J, Zhang Y, Lv S, Song W, Huang Y, Chen X. Li M, et al. Adv Healthc Mater. 2014 Nov;3(11):1877-88. doi: 10.1002/adhm.201400108. Epub 2014 May 20. Adv Healthc Mater. 2014. PMID: 24846434

9

Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.

Lv S, Tang Z, Zhang D, Song W, Li M, Lin J, Liu H, Chen X. Lv S, et al. Among authors: li m. J Control Release. 2014 Nov 28;194:220-7. doi: 10.1016/j.jconrel.2014.09.009. Epub 2014 Sep 16. J Control Release. 2014. PMID: 25220162

10

Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.

Li M, Tang Z, Zhang Y, Lv S, Li Q, Chen X. Li M, et al. Among authors: li q. Acta Biomater. 2015 May;18:132-43. doi: 10.1016/j.actbio.2015.02.022. Epub 2015 Feb 28. Acta Biomater. 2015. PMID: 25735801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,345 results

Search Page

Filters